The London Stock Exchange has raised the alarm that as many as 200 companies could consider moving their listings from the UK to the US under a worst-case scenario, deepening fears over London's ability to retain major public firms and high-growth fintech companies. The warning, part of an internal scenario assessment, estimates the UK Treasury could face a revenue shortfall of roughly £2 billion if migration accelerates.
The risk spans both blue-chip corporations and smaller fintech firms. The damage is not limited to formal delistings; more damaging is the gradual shift of trading activity, liquidity and investor attention toward US markets. A company does not need to fully exit London for the exchange to lose influence. If investors treat a US listing as the primary market, trading volumes follow, valuation benchmarks shift, and the UK connection becomes less relevant. Over time, that discourages other companies from choosing London as their primary listing venue.
The 0.5% Obstacle: Stamp Duty
At the center of the policy debate is the UK's 0.5% stamp duty on share purchases. Market participants have long argued that this levy raises trading costs, reduces liquidity, and puts UK-listed equities at a structural disadvantage compared to US stocks, which face no equivalent tax. The impact is most severe for growth companies that rely on deep capital pools, active institutional trading, and strong secondary-market demand.
The UK government faces a difficult trade-off. Scrapping stamp duty could make London more competitive and help retain trading activity, but it would also eliminate a significant source of tax revenue. Keeping the levy protects near-term receipts but risks driving more activity overseas, eroding the tax base in the long run. The LSE's warning transforms stamp duty from a technical tax issue into a broader market-structure problem: if the tax makes London less attractive for investors, the UK risks losing not only listings but also the liquidity and valuation support that make a public market valuable.
AstraZeneca and Wise: Early Warnings
The warning has gained urgency after high-profile shifts by AstraZeneca and Wise. Wise, one of the UK's best-known fintech firms, moved its primary listing to the US while retaining a London presence, a blow to the city's ambitions to become a hub for tech listings. AstraZeneca strengthened its New York market presence while keeping its UK listing and headquarters, raising concerns that other major UK-listed firms could follow similar paths. These cases illustrate how listing migration can happen gradually: a company keeps a UK identity but allows liquidity and valuation attention to drift toward New York, a softer form of migration that is harder to measure but equally damaging over time.
What's at Stake: A Self-Reinforcing Decline
London is competing against deeper US capital markets, higher valuations, and stronger investor demand for growth companies. The LSE's scenario does not mean 200 firms are ready to leave immediately, but it signals the scale of risk if current pressures persist. For policymakers, the question is whether the UK can retain enough market activity to sustain its role as a primary listing venue. For boards, the decision becomes increasingly practical: if the US offers better trading depth, stronger valuations, and no stamp duty, justifying London as the main market becomes difficult. The deeper risk is that London's decline becomes self-reinforcing. More companies moving liquidity to New York means less investor attention on UK markets; less attention deters future issuers, leaving the UK with fewer major public companies, thinner trading, and a weakened claim to being a global equity hub.